Joincare Pharmaceutical Group Industry Co.,Ltd.

XSSC:600380 Stock Report

Market Cap: CN¥20.9b

Joincare Pharmaceutical Group IndustryLtd Future Growth

Future criteria checks 1/6

Joincare Pharmaceutical Group IndustryLtd is forecast to grow earnings and revenue by 11.8% and 8.3% per annum respectively. EPS is expected to grow by 11.9% per annum. Return on equity is forecast to be 10.7% in 3 years.

Key information

11.8%

Earnings growth rate

11.9%

EPS growth rate

Pharmaceuticals earnings growth19.0%
Revenue growth rate8.3%
Future return on equity10.7%
Analyst coverage

Low

Last updated28 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:600380 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202619,3721,921N/A4,2563
12/31/202518,3181,694N/A3,8934
12/31/202416,9631,528N/A4,3874
9/30/202415,8941,4712,9694,083N/A
6/30/202416,1611,4043,2864,409N/A
3/31/202416,4271,4203,5194,653N/A
12/31/202316,6461,4432,7993,929N/A
9/30/202316,7821,4602,9033,829N/A
6/30/202317,2981,5172,3833,332N/A
3/31/202317,0441,5052,2393,354N/A
12/31/202217,1431,5032,8303,978N/A
9/30/202216,9821,4462,0143,551N/A
6/30/202216,6331,4422,0573,720N/A
3/31/202216,4161,4221,4682,940N/A
12/31/202115,9041,3281,0422,563N/A
9/30/202115,3521,2021,3872,662N/A
6/30/202114,8811,1321,3692,522N/A
3/31/202114,4791,2072,0053,037N/A
12/31/202013,5221,1202,1953,025N/A
9/30/202012,7921,0431,8132,515N/A
6/30/202012,1711,0241,7852,430N/A
3/31/202011,8268691,5642,239N/A
12/31/201911,9808941,6092,312N/A
9/30/201911,8588371,9492,614N/A
6/30/201911,7418202,0552,701N/A
3/31/201911,5367791,4452,059N/A
12/31/201811,2046991,1711,826N/A
9/30/201811,2087499401,593N/A
6/30/201811,0832,232N/A1,518N/A
3/31/201811,0302,167N/A1,790N/A
1/1/201810,7792,133N/A1,870N/A
9/30/201710,5622,103N/A1,690N/A
6/30/201710,254521N/A1,713N/A
3/31/201710,125484N/A1,779N/A
12/31/20169,722451N/A1,645N/A
9/30/20169,546346N/A1,699N/A
6/30/20169,373337N/A1,388N/A
3/31/20168,881393N/A1,354N/A
12/31/20158,642412N/A1,265N/A
9/30/20158,317492N/A1,132N/A
6/30/20158,031487N/A1,125N/A
3/31/20157,802412N/A968N/A
12/31/20147,418354N/A979N/A
9/30/20147,413319N/A700N/A
6/30/20146,869298N/A604N/A
3/31/20146,463282N/A717N/A
12/31/20136,220274N/A636N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600380's forecast earnings growth (11.8% per year) is above the savings rate (2.8%).

Earnings vs Market: 600380's earnings (11.8% per year) are forecast to grow slower than the CN market (26.2% per year).

High Growth Earnings: 600380's earnings are forecast to grow, but not significantly.

Revenue vs Market: 600380's revenue (8.3% per year) is forecast to grow slower than the CN market (13.8% per year).

High Growth Revenue: 600380's revenue (8.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600380's Return on Equity is forecast to be low in 3 years time (10.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y